Literature DB >> 24634707

Glutamate and the Treatment of Obsessive-Compulsive Disorder.

Frank P Macmaster1, David R Rosenberg2.   

Abstract

Entities:  

Year:  2010        PMID: 24634707      PMCID: PMC3951158          DOI: 10.1097/01.IDT.0000371059.45965.88

Source DB:  PubMed          Journal:  Psychopharm Rev        ISSN: 1936-9255


× No keyword cloud information.
  33 in total

Review 1.  Clinical practice. Obsessive-compulsive disorder.

Authors:  Michael A Jenike
Journal:  N Engl J Med       Date:  2004-01-15       Impact factor: 91.245

2.  Functional and biochemical alterations of the medial frontal cortex in obsessive-compulsive disorder.

Authors:  Murat Yücel; Ben J Harrison; Stephen J Wood; Alex Fornito; Robert M Wellard; Jesus Pujol; Kerrie Clarke; Mary L Phillips; Michael Kyrios; Dennis Velakoulis; Christos Pantelis
Journal:  Arch Gen Psychiatry       Date:  2007-08

3.  N-acetylcysteine augmentation in serotonin reuptake inhibitor refractory obsessive-compulsive disorder.

Authors:  Daniel L Lafleur; Christopher Pittenger; Ben Kelmendi; Tom Gardner; Suzanne Wasylink; Robert T Malison; Gerard Sanacora; John H Krystal; Vladimir Coric
Journal:  Psychopharmacology (Berl)       Date:  2005-12-22       Impact factor: 4.530

4.  Riluzole augmentation in treatment-resistant obsessive-compulsive disorder: an open-label trial.

Authors:  Vladimir Coric; Sarper Taskiran; Christopher Pittenger; Suzanne Wasylink; Daniel H Mathalon; Gerald Valentine; John Saksa; Yu-Te Wu; Ralitza Gueorguieva; Gerard Sanacora; Robert T Malison; John H Krystal
Journal:  Biol Psychiatry       Date:  2005-09-01       Impact factor: 13.382

5.  Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication.

Authors:  Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Kathleen R Merikangas; Ellen E Walters
Journal:  Arch Gen Psychiatry       Date:  2005-06

6.  A family study of obsessive-compulsive disorder.

Authors:  D L Pauls; J P Alsobrook; W Goodman; S Rasmussen; J F Leckman
Journal:  Am J Psychiatry       Date:  1995-01       Impact factor: 18.112

7.  Association of the SLC1A1 glutamate transporter gene and obsessive-compulsive disorder.

Authors:  S Evelyn Stewart; Jesen A Fagerness; Jill Platko; Jordan W Smoller; Jeremiah M Scharf; Cornelia Illmann; Eric Jenike; Nadia Chabane; Marion Leboyer; Richard Delorme; Michael A Jenike; David L Pauls
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2007-12-05       Impact factor: 3.568

Review 8.  Long-term outcome of pediatric obsessive-compulsive disorder: a meta-analysis and qualitative review of the literature.

Authors:  S E Stewart; D A Geller; M Jenike; D Pauls; D Shaw; B Mullin; S V Faraone
Journal:  Acta Psychiatr Scand       Date:  2004-07       Impact factor: 6.392

9.  Central challenges facing the national clinical research enterprise.

Authors:  Nancy S Sung; William F Crowley; Myron Genel; Patricia Salber; Lewis Sandy; Louis M Sherwood; Stephen B Johnson; Veronica Catanese; Hugh Tilson; Kenneth Getz; Elaine L Larson; David Scheinberg; E Albert Reece; Harold Slavkin; Adrian Dobs; Jack Grebb; Rick A Martinez; Allan Korn; David Rimoin
Journal:  JAMA       Date:  2003-03-12       Impact factor: 56.272

10.  Mapping autism risk loci using genetic linkage and chromosomal rearrangements.

Authors:  Peter Szatmari; Andrew D Paterson; Lonnie Zwaigenbaum; Wendy Roberts; Jessica Brian; Xiao-Qing Liu; John B Vincent; Jennifer L Skaug; Ann P Thompson; Lili Senman; Lars Feuk; Cheng Qian; Susan E Bryson; Marshall B Jones; Christian R Marshall; Stephen W Scherer; Veronica J Vieland; Christopher Bartlett; La Vonne Mangin; Rhinda Goedken; Alberto Segre; Margaret A Pericak-Vance; Michael L Cuccaro; John R Gilbert; Harry H Wright; Ruth K Abramson; Catalina Betancur; Thomas Bourgeron; Christopher Gillberg; Marion Leboyer; Joseph D Buxbaum; Kenneth L Davis; Eric Hollander; Jeremy M Silverman; Joachim Hallmayer; Linda Lotspeich; James S Sutcliffe; Jonathan L Haines; Susan E Folstein; Joseph Piven; Thomas H Wassink; Val Sheffield; Daniel H Geschwind; Maja Bucan; W Ted Brown; Rita M Cantor; John N Constantino; T Conrad Gilliam; Martha Herbert; Clara Lajonchere; David H Ledbetter; Christa Lese-Martin; Janet Miller; Stan Nelson; Carol A Samango-Sprouse; Sarah Spence; Matthew State; Rudolph E Tanzi; Hilary Coon; Geraldine Dawson; Bernie Devlin; Annette Estes; Pamela Flodman; Lambertus Klei; William M McMahon; Nancy Minshew; Jeff Munson; Elena Korvatska; Patricia M Rodier; Gerard D Schellenberg; Moyra Smith; M Anne Spence; Chris Stodgell; Ping Guo Tepper; Ellen M Wijsman; Chang-En Yu; Bernadette Rogé; Carine Mantoulan; Kerstin Wittemeyer; Annemarie Poustka; Bärbel Felder; Sabine M Klauck; Claudia Schuster; Fritz Poustka; Sven Bölte; Sabine Feineis-Matthews; Evelyn Herbrecht; Gabi Schmötzer; John Tsiantis; Katerina Papanikolaou; Elena Maestrini; Elena Bacchelli; Francesca Blasi; Simona Carone; Claudio Toma; Herman Van Engeland; Maretha de Jonge; Chantal Kemner; Frederieke Koop; Frederike Koop; Marjolein Langemeijer; Marjolijn Langemeijer; Channa Hijmans; Channa Hijimans; Wouter G Staal; Gillian Baird; Patrick F Bolton; Michael L Rutter; Emma Weisblatt; Jonathan Green; Catherine Aldred; Julie-Anne Wilkinson; Andrew Pickles; Ann Le Couteur; Tom Berney; Helen McConachie; Anthony J Bailey; Kostas Francis; Gemma Honeyman; Aislinn Hutchinson; Jeremy R Parr; Simon Wallace; Anthony P Monaco; Gabrielle Barnby; Kazuhiro Kobayashi; Janine A Lamb; Ines Sousa; Nuala Sykes; Edwin H Cook; Stephen J Guter; Bennett L Leventhal; Jeff Salt; Catherine Lord; Christina Corsello; Vanessa Hus; Daniel E Weeks; Fred Volkmar; Maïté Tauber; Eric Fombonne; Andy Shih; Kacie J Meyer
Journal:  Nat Genet       Date:  2007-02-18       Impact factor: 38.330

View more
  1 in total

1.  Fluvoxamine induced oculogyric dystonia and manic switch in a patient with obsessive compulsive disorder.

Authors:  Sai Krishna Tikka; Shobit Garg; Basudeb Das
Journal:  Indian J Pharmacol       Date:  2013 Sep-Oct       Impact factor: 1.200

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.